Jiang Quan, Bai Jin, He Mulan, Yuen Karen W Y, Wong Anderson O L
School of Biological Sciences, The University of Hong Kong, Hong Kong, China.
College of Life Sciences, Sichuan University, Chengdu, China.
Front Endocrinol (Lausanne). 2018 Jun 21;9:336. doi: 10.3389/fendo.2018.00336. eCollection 2018.
In mammals, insulin is known to modify growth hormone (GH)-induced IGF-I expression at the hepatic level, which also contributes to the functional crosstalk between energy homeostasis and somatotropic axis. However, the studies on the comparative aspects of this phenomenon are limited and the mechanisms involved have not been fully characterized. Using a serum-free culture of grass carp hepatoctyes, the functional interaction between GH and insulin on hepatic expression of IGF-I and -II was examined in a fish model. In carp hepatocytes, GH could up-regulate IGF-I and -II mRNA expression via the JAK/STAT, MEK/ERK and PI3K/Akt pathways. These stimulatory effects were mimicked by insulin via activation of the PI3K/Akt but not MEK/ERK and P38 MAPK cascades. Although insulin did not activate JAK and STAT at hepatocyte level, insulin-induced IGF-I and -II mRNA expression were highly dependent on the normal functioning of JAK/STAT pathway. In parallel experiments, insulin co-treatment was found to markedly enhance IGF-I and -II responses induced by GH and these potentiating effects were mediated by insulin receptor (InsR) but not IGF-I receptor. Interestingly, co-treatment with GH also enhanced insulin-induced InsR phosphorylation with a current elevation in protein:protein interaction between GH receptor and phosphorylated InsR and these stimulatory effects were noted with further enhancement in STAT, ERK and Akt phosphorylation at hepatocyte level. Consistent with these findings, the potentiating effects of GH and insulin co-treatment on IGF-I and -II mRNA expression were found to be suppressed/abolished by inhibiting JAK/STAT, MEK/ERK and PI3K/Akt but not P38 MAPK pathways. These results, as a whole, suggest that insulin and GH can act in a synergistic manner in the carp liver to up-regulate IGF-I and -II expression through protein:protein interaction at the receptor level followed by potentiation in post-receptor signaling.
在哺乳动物中,已知胰岛素可在肝脏水平调节生长激素(GH)诱导的IGF-I表达,这也有助于能量稳态与生长激素轴之间的功能串扰。然而,关于这一现象比较方面的研究有限,所涉及的机制尚未完全阐明。利用草鱼肝细胞的无血清培养,在鱼类模型中研究了GH和胰岛素对肝脏IGF-I和IGF-II表达的功能相互作用。在鲤鱼肝细胞中,GH可通过JAK/STAT、MEK/ERK和PI3K/Akt途径上调IGF-I和IGF-II mRNA表达。胰岛素通过激活PI3K/Akt而非MEK/ERK和P38 MAPK级联反应模拟了这些刺激作用。尽管胰岛素在肝细胞水平未激活JAK和STAT,但胰岛素诱导的IGF-I和IGF-II mRNA表达高度依赖于JAK/STAT途径的正常功能。在平行实验中,发现胰岛素联合处理可显著增强GH诱导的IGF-I和IGF-II反应,这些增强作用由胰岛素受体(InsR)介导,而非IGF-I受体。有趣的是,与GH联合处理也增强了胰岛素诱导的InsR磷酸化,同时GH受体与磷酸化InsR之间的蛋白质-蛋白质相互作用增加,并且在肝细胞水平观察到STAT、ERK和Akt磷酸化进一步增强。与这些发现一致,发现通过抑制JAK/STAT、MEK/ERK和PI3K/Akt而非P38 MAPK途径可抑制/消除GH和胰岛素联合处理对IGF-I和IGF-II mRNA表达的增强作用。总体而言,这些结果表明,胰岛素和GH可在鲤鱼肝脏中协同作用,通过受体水平的蛋白质-蛋白质相互作用上调IGF-I和IGF-II表达,随后增强受体后信号传导。